Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Invested Capital (2016 - 2017)

Historic Invested Capital for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $2.7 million.

  • Bone Biologics' Invested Capital rose 3341.68% to $2.7 million in Q3 2017 from the same period last year, while for Sep 2017 it was $2.7 million, marking a year-over-year increase of 3341.68%. This contributed to the annual value of -$7.2 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Bone Biologics reported Invested Capital of $2.7 million as of Q3 2017, which was up 3341.68% from $2.5 million recorded in Q2 2017.
  • In the past 5 years, Bone Biologics' Invested Capital ranged from a high of $4.4 million in Q1 2017 and a low of -$7.2 million during Q4 2016